Targeting focal adhesion kinase with dominant-negative FRNK or Hsp90 inhibitor 17-DMAG suppresses tumor growth and metastasis of SiHa cervical xenografts.

Targeting focal adhesion kinase with dominant-negative FRNK or Hsp90 inhibitor 17-DMAG suppresses tumor growth and metastasis of SiHa cervical xenografts.

Item
http://www.wikidata.org/entity/Q39848848
Stabilization of integrin-linked kinase by the Hsp90-CHIP axis impacts cellular force generation, migration and the fibrotic responseSNAI1 expression and the mesenchymal phenotype: an immunohistochemical study performed on 46 cases of oral squamous cell carcinomaHeat shock protein 90β stabilizes focal adhesion kinase and enhances cell migration and invasion in breast cancer cellsAnoikis mediators in oral squamous cell carcinoma.Optical imaging with her2-targeted affibody molecules can monitor hsp90 treatment response in a breast cancer xenograft mouse modelHeat shock protein 90 is involved in the regulation of HMGA2-driven growth and epithelial-to-mesenchymal transition of colorectal cancer cells.Aberrant methylation-mediated silencing of microRNAs contributes to HPV-induced anchorage independence.Therapeutic potential and limitations of new FAK inhibitors in the treatment of cancer.Therapeutic targeting of tumor-stroma interactions.Targeting FAK in human cancer: from finding to first clinical trials.Meaningful prevention of breast cancer metastasis: candidate therapeutics, preclinical validation, and clinical trial concerns.Vascular endothelial growth factor C enhances cervical cancer migration and invasion via activation of focal adhesion kinase.The role of focal adhesion kinase catalytic activity on the proliferation and migration of squamous cell carcinoma cells.Exploring the interaction between human focal adhesion kinase and inhibitors: a molecular dynamic simulation and free energy calculations.High FAK combined with low JWA expression: clinical prognostic and predictive role for adjuvant fluorouracil-leucovorin-oxaliplatin treatment in resectable gastric cancer patients.
P2860

Targeting focal adhesion kinase with dominant-negative FRNK or Hsp90 inhibitor 17-DMAG suppresses tumor growth and metastasis of SiHa cervical xenografts.

Item
http://www.wikidata.org/entity/Q39848848
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Targeting focal adhesion kinas ...... s of SiHa cervical xenografts.
@en
Targeting focal adhesion kinas ...... s of SiHa cervical xenografts.
@nl
type
label
Targeting focal adhesion kinas ...... s of SiHa cervical xenografts.
@en
Targeting focal adhesion kinas ...... s of SiHa cervical xenografts.
@nl
prefLabel
Targeting focal adhesion kinas ...... s of SiHa cervical xenografts.
@en
Targeting focal adhesion kinas ...... s of SiHa cervical xenografts.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P356
P1433
P1476
Targeting focal adhesion kinas ...... s of SiHa cervical xenografts.
@en
P2093
P304
P31
P356
10.1158/0008-5472.CAN-09-0454
P407
P433
P478
P50
P577
P5875
P698
P921